Ion-Pairing with Spermine Targets Theophylline to the Lungs via the Polyamine Transport System by Benaouda, Faiza et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1021/acs.molpharmaceut.7b00715
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Benaouda, F., Jones, S. A., Chana, J., Dal Corno, B. M., Barlow, D. J., Hider, R. C., ... Forbes, B. (2018). Ion-
Pairing with Spermine Targets Theophylline to the Lungs via the Polyamine Transport System. Molecular
Pharmaceutics, 15(3), 861-870. https://doi.org/10.1021/acs.molpharmaceut.7b00715
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 05. Apr. 2019
1 
 
Ion-pairing with spermine targets theophylline to the lungs via the polyamine transport system  
 
Faiza. Benaouda1, Stuart. A. Jones1*, Jasminder. Chana1, Benedetta. M. Dal Corno1, Dave. J. 
Barlow1, Robert. C. Hider1, Clive. P. Page1,2, Ben Forbes1 
 
1Institute of Pharmaceutical Science, King’s College London, Franklin-Wilkins Building, 150 
Stamford Street, London, SE1 9NH. 
2Sackler Institute of Pulmonary Pharmacology, King’s College London, Franklin-Wilkins 
Building, 150 Stamford Street, London, SE 1 9NH. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Corresponding author: Dr. S. A. Jones. King’s College London, Institute of Pharmaceutical 
Science, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH. Tel: +44 (0)207 
848 4843. Fax: +44 (0)207 848 4800. E-mail: stuart.jones@kcl.ac.uk 
 
2 
 
Graphical Abstract 
 
 
 
 
 
  
0
3
6
9
12
15
THE THE-SPE THE-SPE (PG)
D
ru
g
 r
e
ta
in
e
d
 i
n
 t
h
e
 l
u
n
g
s
 
(m
g
/g
 t
is
s
u
e
)
*
*
3 
 
Abstract 
 
Certain xenobiotics, such as paraquat, are sequestered into the lungs from the systemic 
circulation by the polyamine transporter system (PTS). The aim of this study was to investigate 
whether ion-pairing a drug (theophylline) with a PTS substrate (spermine) provides a means of 
using this active transport mechanism to target drug delivery to the lungs. Fourier transform 
infrared spectroscopy showed that two of the amines of spermine interact with C-N7 and C6=O 
of theophylline, leaving two free amines to interact with the PTS. In A549 cells, which possess 
a functional PTS (spermidine Km and Vmax, 0.6 ± 0.3 mM and 1.8 ± 0.3 pmol.min-1 per 105 cells, 
respectively), uptake of the theophylline-spermine ion-pair was increased 1.8-fold compared 
to free theophylline at 37°C, but not at 4°C.  In an isolated perfused rat lung model (IPL) a 3.6-
fold increase in lung theophylline concentration was observed after vascular administration of 
the ion-pair compared to free theophylline. Theophylline was cleared from the IPL with similar 
kinetics irrespective of whether it was delivered as the free drug or an ion-pair, although lung 
levels remained elevated after washout following delivery as an ion-pair. In vitro simulation of 
the theophylline-spermine break down demonstrated that a drop in pH from 9.6 to 7.4, such as 
that undergone by the ion-pair in biological matrices, induces rapid and almost complete 
dissociation of the ion-paired species. However, infusion of the ion-pair formulations via the 
vasculature provides almost immediate delivery to the pulmonary capillary bed permitting 
PTS-mediated active sequestering of ion-paired theophylline into the lungs. 
 
Keywords: Polyamine; ion pair; lung; theophylline; active uptake; isolated perfused lung; 
A549. drug targeting 
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1 Introduction 
 
The polyamine transporter system (PTS) has been identified in both prokaryotic and 
eukaryotic cells 1. It transports polyamines in a saturable, carrier-mediated, time, temperature, 
pH, energy and concentration-dependent manner 2. The PTS has the capacity to sequester 
certain xeniobiotics from the systemic circulation into the pulmonary system 1,3 and thus offers 
a potential means by which to target drug delivery to the lungs. 
 
A gene for the mammalian polyamine transporter has not yet been identified, but 
structure-activity studies have established that good PTS substrates require two or more N-
containing moieties that are protonated at physiological pH 4. As very few therapeutic agents 
that require delivery into the lungs display these structural characteristics, a number of 
polyamine drug analogues and covalent polyamine drug conjugates have been developed in an 
attempt to use the PTS to target delivery to the lungs 5-7. However, these strategies have had 
limited success because combining the molecular features required for effective active PTS 
transport and pharmacological action in a single molecule is problematic 5-7. An alternative, 
but untested approach, to utilising the PTS to target drug delivery to the lungs is to form non-
covalent polyamine complexes such as ion-pairs. If sufficiently tightly complexed ion-pairs 
could be transported from the vasculature into the lungs by the PTS, before dissociating to 
release the drug to elicit its pharmacological effect. 
 
The association of two oppositely charged molecules in the solution state to form ion-
pairs (A-B+) has been shown to alter the transport of ionised molecules into the skin 8, across 
the nasal mucosa 9 and across the intestinal mucosa 10. In these previous studies the counter 
ions used for ion-pair formation altered the drug transport rate through modification of the 
parent drug’s physicochemical characteristics, which affected the molecules absorption. The 
formation of ion-pairs has also been shown to enable active transport into cells by an energy 
dependent mechanism 11 and it is possible, therefore, that linking a therapeutic agent to a PTS 
substrate via ion-pairing may facilitate sequestration of the drug into the lungs. 
 
The aim of the present study was to investigate whether forming a non-covalently bound 
ion-pair complex between theophylline and spermine can enable active drug uptake into the 
lungs. Spermine, a tetra-amine, which displays a high affinity for the PTS (Ki ca. 0.02 µM) 
2, 
was utilised as the ion-pair counter ion and theophylline was used as the model drug. 
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Theophylline contains an acidic nitrogen with a pKa of 8.6 and hence it has the potential to 
form an ion-pair with spermine both at the commercial intravenous formulation pH of 9.4 
(Phyllocontin®), and under physiological conditions, pH 7.4. Although the reduction in 
theophylline ionisation driven by the pH drop from 9.4 to 7.4 upon administration would 
theoretically weaken the theophylline-spermine ion-pair it was predicted that the ion-pair 
stability, which is dependent on association strength 8, would be sufficient to influence uptake 
into the lung after intravenous administration. 
 
The PTS function has been characterised in rat lung slices12-14 and it has been shown to 
mediate polyamine uptake into type I and type II pulmonary epithelial cells; it is also active in 
pulmonary artery endothelial cells15,16. Although a rat endothelial cell-line with an active 
polyamine transport system has been reported17, comparatively few studies have used this 
model to assess drug transport18 and therefore in this work the A549 human alveolar epithelial 
cell line was selected to study the kinetics of PTS-mediated uptake of ion-paired theophylline. 
Although the A549 cell line does not model the capillary endothelium, the objective of the cell 
culture studies was to evaluate whether formulating theophylline as an ion-pair can modify 
drug transport kinetics.  The A549 cell line was used as a robust model, in which PTS activity 
is well characterised, before the formulation approach was tested in isolated perfused lungs 
(IPL)2. In the IPL the ion-pair formulations were administered to the vasculature in either 
plasma protein-containing or protein-free perfusate. The ion-pair dissociation kinetics could 
not be monitored in physiological fluids using commercial analytical apparatus due to solvent 
signal interference with the spectrum, therefore an in vitro model was used to simulate the pH 
change upon introduction of the ion-pair (pH 9.6) into the perfusate (pH 7.4) and investigate 
temporal complex association. Ion-pair dissociation rate data were used to interpret 
theophylline kinetics in the IPL studies, thus determine whether modified lung uptake was 
consistent with active sequestration of a labile ion-pair. 
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2. Materials and Methods 
 
2.1 Materials 
Theophylline (anhydrous, ≥ 99%), propylene glycol (PG, USP grade), spermine (≥ 
99%), hydrochloric acid (HCl), and Krebs buffer salts (NaCl, KCl, CaCl2, MgSO4, NaHCO3, 
KH2PO4, 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES), and D-glucose), were 
supplied by Sigma Aldrich, UK. STEEN solution ((human serum albumin, dextran-40, NaCl, 
glucose, KCl, Na H2PO4, CaCl2H2, MgCl, NaHCO3, NaOH and water for injection) was 
obtained from XVIVO Perfusion AB, Sweden. Methanol (high performance liquid 
chromatography (HPLC) grade) and Optiphase “Safe” scintillation cocktail were obtained from 
Fisher Scientific International, UK. Heparin was purchased from Movianto UK Ltd, saline (0.9 
%w/v) from Baxter, UK and tissue solubilizer Soluene-350, was obtained from PerkinElmer, 
UK. 8-14C theophylline (60 mCi/mmol, > 98%) and 1,4-14C spermidine trihydrochloride (3.7 
mCi/mmol, > 98 %) were obtained from American Radiochemicals, USA. A549 cells were 
obtained from ATCC, USA and all reagents for the cell culture (Minimum Essential Medium 
Eagle, fetal bovine serum (FBS), L-glutamine, non-essential amino acids, gentamicin, trypsin-
EDTA (0.25% trypsin, 0.05% EDTA), Hank’s Balanced Salt Solution, trypan blue and Triton 
X), and deuterated water were all purchased from Sigma Aldrich, UK.  
 
2.2 Ion-pair Characterisation 
The conditional theophylline-spermine association constants (pKcond) were determined 
using solution-state Fourier transform infrared spectroscopy (FTIR). A universal transmission 
cell system (Omni-Cell, Specac Ltd., UK) fitted with CaF2 windows and a 25 mm Mylar spacer 
(Specac Ltd., UK) was used for transmission measurements. Theophylline (3.6 mg.mL-1) and 
spermine (from 0 to 83 mg.mL-1) were combined to achieve theophylline:spermine molar ratios 
of 1:0-1:10 in water and 1:0-1:20 in PG-water solvents. The theophylline ionisation 
(theophylline pKa = 8.6 at the acidic N7 
19) and spermine ionisation (spermine pKa’s = 
10.8(N1), 10.2(N2), 8.85(N3) and 7.95(N4) 
19) were maintained constant during the ion-pair 
affinity measurements by adjusting the final pH of all the solutions to pH 9.6 ± 0.2 using 
sodium hydroxide or hydrochloric acid when appropriate (at this pH 86% of the theophylline 
was ionised and 97%, 84%, 26%, 4% of the spermine at the N1, N2, N3 and N4 sites, 
respectively, was ionised). Deuterated water (D2O) was employed in the measurements as it 
allowed accurate detection of theophylline absorption bands in the 1700-1500 cm-1 range. 
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All infrared spectra were recorded using a Spectrum One spectrometer (Perkin Elmer 
Ltd., UK) and spectral analysis was performed with Spectrum version 10 software (Perkin 
Elmer Ltd., UK). The spectra were generated from 32 scans collected at a spectral resolution 
of 4 cm-1. The vehicle spectrum containing the equivalent amount of the spermine (and HCl 
when appropriate) was subtracted from the sample spectrum. The peak height of the normalised 
theophylline C-N7 stretching bands, previously assigned to the uncomplexed (1551 cm
-1) and 
complexed (1530 cm-1) species 20, 21, were employed to construct plots of % theophylline-
spermine complex formed vs –log[spermine]free. These data were fitted with a sigmoidal 
regression model (SigmaPlot 12.0, Systat Software Inc, UK) to determine the pKcond. The 
pKcond was derived on the assumption that theophylline and spermine formed a 1:1 complex, 
as indicated by in-silico modelling (Chem3D, Perkin Elma, UK) which suggested that such a 
complex would form 2 hydrogen bonds. The apparent stability constant (pKapp) of the 
theophylline-spermine complex was calculated by correcting for the acidity constant of 
spermine (1.09) which accounted for the incomplete ionisation at the N1 of spermine, which 
was directly involved in forming the ion-pair. 
 
The formation of the theophylline-spermine complex was confirmed using a high 
performance liquid chromatography (HPLC) method based on work by Horvath et al., 22. The 
retention time of the theophylline (36 mg.mL-1) was obtained by injecting 20 mL into the HPLC 
system with a mobile phase consisting of methanol:water (10:90 v/v, pH 9.6 ± 0.3). The HPLC 
system (HP1050, UK) was a quaternary pump set at a flow rate of 1 mL.min-1 and a single 
wavelength UV detector set at 274 nm. The stationary phase was a reversed-phase octadecyl 
silane (ODS-2) 5 μm column (250 × 4.6 mm). The pH of the mobile phase was carefully 
maintained at pH 9.6 ± 0.3 and checked prior to, and post sample injection. 
 
2.3 Cell culture studies 
The human alveolar epithelial cell line A549 was used between passages 90-115. The 
cultures were maintained in a humidified 5% CO2/ 95% atmospheric air incubator at 37°C. Cell 
culture medium comprised Minimum Essential Eagle Medium supplemented with FBS (10 % 
(v/v)), L-glutamine (200 mM, 40% (v/v)) and gentamicin (50 mg/ml, 0.1 % (v/v)). Medium 
was exchanged every 2-3 days and cells were passaged weekly at a 1:3 split ratio using trypsin-
EDTA solution. Cells were harvested and seeded in 24-well tissue culture plates (Greiner 
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cellstar, Sigma Aldrich, UK) at a density of 2 × 105 cells/well and used for uptake studies once 
a confluent cell layer had been established. 
 
To assess the functionality of the PTS in A549 cells, 14C-spermidine uptake was 
measured.  After the cells were washed with HBSS and immersed in fresh HBSS (0.5 mL), 
uptake studies were initiated by the addition of 0.5 mL spermidine solutions (in water at pH 
7.4 and 9.6 ± 0.2), at varying concentrations (final 14C-spermidine concentrations ranging from 
0.12 to 1.7 mM. At given time points up to 40 min, the experiments were terminated by 
aspirating the culture medium. To displace any 14C-spermidine attached to the cell surface, the 
cells were washed with ice-cold HBSS. The cells were then lysed by the addition of a 1% Triton 
X100 solution for 45 min at 37°C. The activity in the culture medium, the cell washings and 
that associated with the lysed cells was determined by scintillation counting following the 
addition of scintillation cocktail on a LS6500 multipurpose scintillation counter (Beckman, 
USA). The uptake kinetics for spermine (Km and Vmax) were determined by fitting the data with 
a non-linear regression model (R2 > 0.95) (SigmaPlot 13, Systat Software Inc, UK). 
 
To investigate 14C-theophylline uptake, the culture medium was removed, the cells 
were washed with HBSS and then immersed in HBSS (0.5 mL). Uptake studies were initiated 
by the addition of 0.5 mL of either theophylline control (theophylline at 0.06 mg.mL-1 in water 
at pH 7.4 or at pH 9.6 ± 0.2), theophylline-spermine non-ion-paired (theophylline at 0.06 
mg.mL-1 and spermine at 1.34 mg.mL-1 in water, pH 7.4) or ion-paired theophylline:spermine 
(theophylline at 0.06 mg.mL-1 and spermine at 1.34 mg.mL-1 in water, pH 9.6 ± 0.2). The mixing 
of the HBSS with the theophylline solutions generated solutions that were tolerated by the cells 
(pH 8.3, tolerability determined by MTT tests, data not shown), but did not dilute the ion-pairs 
in the electrolyte solution in advance of the experiments. After an incubation period of 2 min, 
the experiment was stopped and a full mass balance performed as described for spermidine. 
Each condition was tested in triplicate using three different passages of cells. All uptake studies 
were carried out at 37°C and 4°C in order to assess the energy dependence of the uptake 
process.  
 
2.4  Isolated perfused lung studies 
All procedures were performed within the guidelines of the Animals (Scientific 
Procedures) Act 1986 under the authority of approved Home Office personal and project 
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licences. The project was also approved by the local ethics committee at King’s College 
London. Male Wistar rats, (7-8 weeks old, 220 – 260 g), were anesthetised by intraperitoneal 
injection of pentobarbital (280 mg.kg-1). The lungs were excised and perfused through the 
pulmonary artery as previously described 23. Briefly, the trachea was intubated and the lungs 
were inflated in situ with 0.5 mL of air. After laparotomy, heparin sodium (500 IU) was injected 
into the vena cava and the animals were exsanguinated. The pulmonary artery was cannulated 
and perfused with a modified Krebs-Ringer buffer saturated with 95% O2, 5% CO2 
(composition in mM: NaCl 11,8 KCl 4.7, CaCl2 2.5, MgSO4 1.2, NaHCO3 24.9, KH2PO4 1.2, 
HEPES 10, D-glucose 11). The buffer (pH 7.4) was thermostated to 37°C and perfused at a 
constant rate (ca. 8 mL.min-1) maintained by a peristaltic pump (Masterflex, UK). The right 
atrium and ventricles were cut to create an open circuit and allow the unrestricted passage of 
the effluent buffer. The lungs and heart were then excised and suspended by the trachea. The 
lungs were inflated with a further 1.5 mL of air, which provided constant inflation throughout 
the duration of the study. If the lungs maintained viability, determined by the absence of 
significant oedema, they were allowed to stabilize for 2-3 min prior to the initiation of the 
uptake studies. 
 
A total of four theophylline formulations (603 µg.mL-1 14C-theophylline) were assessed 
in the study: (i) theophylline in water (pH 7.4); (ii) theophylline:spermine, 1:20 molar ratio, in 
water, equilibrated for > 4 h prior to use (pH 7.4 ± 0.2); (iii) theophylline:spermine 1:20 molar 
ratio in water (pH 9.6 ± 0.2); and (iv) theophylline:spermine 1:20 molar ratio in PG-water 
(70:30 v/v, (pH 9.6 ± 0.2)). Formulations (i), (iii) and (iv) were introduced into the perfusate 
as it entered the pulmonary artery of the IPL using a syringe pump, with rate set at 0.04 mL.min-
1 (Severn Sales, UK) to achieve a theophylline concentration of 3 µg.mL-1 in the perfusate, 
whereas formulation (ii) was added to the perfusate The formulations were administered via 
single pass perfusion for 25 min followed by a 10 min washout period (perfusion with Kreb’s 
buffer only). At predetermined time points during the infusion and washout periods, 1 mL 
aliquots were removed from the perfusion effluent. At the completion of the washout period, 
the lungs were removed for the measurement of theophylline concentration. The exact 
perfusate and formulation flow rates were normalised using a control run prior to each study, 
which measured the theophylline present at the sampling time points after running through the 
perfusion apparatus in the absence of the lungs. 
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To quantify theophylline in the lung tissue at the end of the infusion, the tissues were 
homogenised (Ultra-Turrax homogeniser) in PBS (1:2 w/v) and solubilised with Soluene-350 
tissue solubilizer (1:5 w/v) (PerkinElmer, UK), under constant shaking for 4 h at 50°C. 
Theophylline was quantified in samples from the perfusion studies and the tissue extraction 
studies by mixing an aliquot of the solutions with 20 mL of Optiphase “Safe” scintillation 
cocktail (Fisher Scientific, UK), acidified with 0.7% v/v glacial acetic acid to eliminate any 
chemi-luminescence. The samples were vortexed and their radioactivity determined using an 
LS6500 multipurpose scintillation counter (Beckman, USA). The lung uptake of 14C-
theophylline during the infusion process was determined by assessing the difference in 
theophylline perfusate concentration in the presence and absence of the lungs. The 
concentration at steady-state (SS) and time to 50% SS (TSS50) were calculated from plots of 
theophylline uptake vs time. The clearance data, obtained from 0-5 min of the washout period, 
were fitted with a second order kinetic model (R2 > 0.95) to determine the elimination rate (K) 
and half-life (T1/2). 
 
To assess the effects of protein binding on the theophylline lung uptake when the 
theophylline:spermine ion-pair was administered, a STEEN/blood mixture (10:4 v/v) was 
employed with the IPL system in a re-circulation mode.  The perfusion was initiated with the 
perfusate containing no drug for ca. 5 min, then either theophylline control or 
theophylline:spermine ion-pairs dissolved in water at pH 9.6 were spiked in the perfusion 
medium to generate a theophylline concentration in the circulating medium of 3 mg.mL-1. After 
25 min, the perfusion reservoir was switched over to a Krebs buffer, at a single pass mode, for 
a 10 min washout period. The amount of theophylline in perfusate samples was quantified as 
described previously. The concentration at steady-state (SS) and time to 50% SS (TSS50) were 
calculated by applying a one-site saturation model (𝑦 =  
𝑆𝑆.  𝑥
𝑆𝑆50+𝑥
) (SigmaPlot 13.0, Systat 
Software Inc, UK) to a plot of theophylline uptake vs time. The clearance data, obtained from 
0-5 min of the washout period, were fitted to a second order kinetic model (
1
[𝑇𝐻𝐸]
=  
1
[𝑇𝐻𝐸]0
+
𝑘𝑇) (R2 > 0.95) to determine the elimination rate (K) and half-life (T1/2).  
 
2.5 Ion-pair dissociation 
To simulate ion-pair dissociation induced by a pH change when introduced into the 
vascular perfusate, theophylline-spermine formulations were made up in D2O and in PG-D2O 
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at pH 9.6 ± 0.2 at a theophylline concentration of 3.6 mg.mL-1 and a spermine concentration of 
83 mg.mL-1. Just prior to measurement, the pH of the test solutions was adjusted to pH 7.4 ± 
0.2 using a pre-determined volume of HCl (5 M). The samples were then mounted in a universal 
transmission cell system (Omni-Cell, Specac Ltd., UK) fitted with CaF2 windows and a 25 µm 
Mylar spacer (Specac Ltd., UK) mounted on a Spectrum One spectrometer (Perkin Elmer Ltd., 
UK). A total of 46 s elapsed before the first scan was taken (time needed to mount the cell onto 
the spectrometer) and the continuous monitoring of the C-N7 and C6=O was carried out for 20 
min using TimeBase™ software (Perkin Elmer Ltd., UK). The pH was monitored throughout 
the process. 
 
2.6 Data Analysis 
Data were expressed as their mean ± standard deviation (SD). Normality (Sapiro-Wilk) 
and homogeneity of variances (Levene's test) were assessed prior to statistical analysis. Lung 
uptake results were analysed using one way analysis of variance (one-way ANOVA) tests with 
post-hoc Tukey analysis where required (Statistical package for social sciences SPSS version 
16.0 (SPSS Inc., Chicago, IL. USA)). All other data were analysed using a Student's t-test 
(SPSS version 16.0 (SPSS Inc., Chicago, IL. USA)). Statistically significant differences were 
assumed when p ≤ 0.05.  
 
3 Results 
 
3.1 Ion-Pairing 
The FTIR spectra of theophylline in D2O displayed characteristic peaks for the C2=O 
stretch at 1698 cm-1, the C6=O at 1647 cm
-1 and the C-N7 stretch at 1551 cm
-1 20,21.. The multiple 
peaks of low intensity around 1530 cm-1 in the C-N stretch region were assigned to theophylline 
dimer formation (Fig.1a) 24.  
 
12 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Characterisation of the theophylline-spermine ion-pair formation; (a) infrared 
spectra; (b) association curves. THE refers to theophylline alone in D2O at pH 9.6, THE-SPE 
the theophylline:spermine ion-pair in D2O at pH 9.6 and THE-SPE PG the ion-pair in a 70/30 
D2O propylene glycol mixture at pH 9.6 (n = 3 ± SD). pKapp is the apparent stability constant. 
In the structure cartoon, H-bonds are shown in green, with atoms coloured as blue = N, dark 
grey = C, red = O, light grey = H. 
 
When spermine was added to the theophylline at a 1:1 ratio the C2=O band split into 
two peaks (1671, 1698 cm-1), the C6=O band split into two peaks (1618, 1647 cm
-1) and the C-
N7 displayed two peaks of similar height (1530, 1551 cm
-1). When the spermine concentration 
was increased to a ratio of 1:20 theophylline:spermine the predominant peaks for the carbonyl 
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were at 1671 cm-1 (C2=O stretching) and 1618 cm
-1 (C2=O stretching), whilst the predominant 
C-N7 peak was at 1531 cm
-1. The up-field peak shifts, i.e., lower wave numbers, resulting from 
the mixing of theophylline with spermine indicated ion-pair formation. The charged amine at 
C-N7 was thought to be the primary site for the ion-pair interaction and therefore the peak 
height ratio at 1530 (ion-paired species) and 1551 cm-1 (non ion-paired species) was used to 
determine the percentage of ion-pair formation at different ratios of theophylline to spermine. 
When the ion-pair was formed in the 70:30 (v/v) PG-D2O vehicle similar up-field shifts for the 
theophylline peaks to those observed in the water vehicle were recorded and so the C-N7 was 
again used to determine the percentage of ion-pair species present in solution. In both vehicles, 
a 1:1 ion-pair complex was thought to be formed between theophylline and spermine, which 
used two of the amines in spermine in the ion-pair interaction leaving two charged amine 
groups for the complex to interact with the PTS (Fig. 1b).  
 
The theophylline-spermine association curve, derived from the FTIR data, was 
sigmoidal (R2 ≥ 0.94) in both D2O and the PG-D2O co-solvent. The association of the 
theophylline-spermine ion-pair in PG-D2O (Fig. 1b) was stronger than in D2O alone (pKapp at 
0.91 ± 0.1 (D2O) vs 1.12 ± 0.1 (PG- D2O)). Using these ion-pair affinity constants, computer 
simulation of the microspecies present in the formulations at pH 9.6 used for the subsequent 
IPL studies, predicted that 33% and 44% of the theophylline would be ion-paired to spermine 
in water and PG:water 70:30 vehicles, respectively (see supporting data Fig. S1). The increase 
in the C18 column retention of theophylline, when presented as the spermine ion-pair compared 
to the theophylline alone, from 4.9 ± 0.0 min to 13.8 ± 0.0 min (n = 3), supported the notion 
that theophylline’s charge was shielded when the ion-pair complex formed and this reduced 
the overall polarity of the theophylline to promote stronger interactions with the hydrophobic 
C18 silica column. 
 
3.2 Cell culture studies  
 
The spermidine uptake kinetics in the A549 cells suggested a single affinity, saturable 
PTS transport mechanism was active with a Km at 0.5 ± 0.1 mM and Vmax at 1.6 ± 0.2 pmol.min-
1 per 105 cells for the pH 7.4-vehicle and Km at 0.6 ± 0.3 mM and Vmax at 1.8 ± 0.3 pmol.min-1 
per 105 cells for the pH 9.6-vehicle (See supporting data Fig. S2). When the spermidine was 
studied at pH 9.6, 500 µL of the pH 9.6 test formulation was added to 500 µL of HBSS (pH 
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7.4) present on the surface of the cells to try mimic the theophylline studies where ion-pair 
dissociation was initiated with this mixing process (a final pH of ca. 8.3, note MTT studies 
showed the cells were viable under both pH 7.4 and pH 8.3 conditions, data not shown). 
Cellular uptake of spermidine was temperature-dependent with a significant decrease (p < 0.01) 
in spermidine uptake when the temperature was lowered to 4°C compared to 37°C (See 
supporting data Fig. S2). The temperature-induced reduction in spermidine uptake (pmol/105 
cells) ranged from 1.9-fold at 1 min to 5.4-fold at 20 min at pH 7.4 and ranged from 1.5-fold 
decrease at 1 min to 3.8-fold decrease at 20 min at pH 9.6.  
 
Presentation of theophylline to the A549 cells as the theophylline:spermine ion-pair 
increased the drug’s uptake at 37°C (p < 0.05) compared to the non-ion-paired controls (Fig. 
2). Reducing the temperature from 37°C to 4°C negated the ion-pair effect on theophylline 
transport into the cells. At 4°C the theophylline cellular uptake from all the test systems 
significantly increased (p < 0.05) compared to that obtained at 37°C, which indicated that 
theophylline may be subject to active efflux from the cells, which was suppressed at 4°C.  
 
 
 
 
 
 
 
 
 
Figure 2. Theophylline (left) uptake by A549 epithelial cells at 37°C and 4°C following the application 
of  theophylline (THE, pH 7.4) (white), theophylline-spermine non-ion-paired (THE-SPE, pH 7.4) 
(light grey) and theophylline-spermine ion-pair (THE-SPE, pH 9.6) (dark grey) to HBSS-submerged 
cells for 2 min. * indicates a statistical difference to the controls (p < 0.05). (n = 3-9 ± SD). 
 
3.3 Isolated perfused lung studies 
 
When theophylline formulations were introduced into the single-pass perfusate 
upstream of the lungs, the lung uptake profile of the theophylline fitted a typical one-
compartment model for continuous infusions, regardless of the formulation used (Fig. 3).  
0.00
0.10
0.20
0.30
0.40
0.50
0.60
37°C 4°C
T
h
e
o
p
h
y
lli
n
e
 u
p
ta
k
e
 (
p
M
o
le
) 
  
  
  
*
15 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Theophylline uptake in a single-pass isolated perfused lung model following 
introduction of theophylline into the perfusate. The theophylline was formulated alone at pH 
7.4 (control) (n = 4 ± SEM) (◊), theophylline-spermine ion-pair in water, pH 9.6 (n = 4 ± SEM) 
(♦) and theophylline-spermine ion-pair in propylene glycol:water 70:30, pH 9.6 (, n = 3 ± 
SEM).  
 
Formulating theophylline as the spermine ion-pair increased the extent of lung uptake 
(p < 0.05) compared to the non-ion-paired control, but the time to establish 50% of the steady-
state levels was unchanged (Table 1). 
 
 
Table 1.   The theophylline uptake in the lung tissue at steady-state (SS), the time to 50% SS 
(TSS50), the rate of lung clearance (K) and lung tissue half-life (T1/2) when theophylline was 
administered into the isolated perfused lung pulmonary circulation perfusate alone (THE), as 
the theophylline-spermine ion-pair in water (THE-SPE) and as the THE-SPE ion-pair in a 
propylene glycol-water vehicle (THE-SPE (PG)) (n = 3-4 ± SD). Dash indicates that the data 
were not collected.*indicates statistically significant difference (p < 0.05) 
 
 
 
Theophylline formulation SS (mg) 
TSS50 
(min) 
K  
(mg-1.min-1) 
T1/2 
(min) 
THE (water, pH 7.4) 25.4 ± 7.2 3.2 ± 3.2 0.1 ± 0.1 0.9 ± 0.7 
THE-SPE (water, pH 9.6) 55.6 ± 11.6* 5.2 ± 6.1 0.1 ± 0.0 1.9 ± 1.3 
THE-SPE (PG:water 70:30, pH 9.6) 96.4 ± 18.0* 2.6 ± 0.5 - - 
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At steady-state, the ion-pair produced a 2.2-fold increase in theophylline lung uptake 
when formulated in the water vehicle and a 3.6-fold increase when formulated in the PG-water 
vehicle compared to the non-ion-paired theophylline (Table 1). Control experiments showed 
that the enhanced lung uptake of the theophylline-ion-pair was not a consequence of delivering 
the drug in a vehicle at pH 9.6 (as there was no difference for free theophylline at pH 9.6 
compared to pH 7.4, p > 0.05, see supporting data Fig S3) or the ‘free’ spermine influencing 
the transport (ion-pair formulation left to dissociate for 4 h in the Krebs vehicle at pH 7.4 
showed no change in the lung uptake, p > 0.05, compared to the free theophylline, see 
supporting data Fig S3). 
 
Upon cessation of the theophylline infusion in the IPL model, the drug cleared from the 
lung tissue rapidly with a lung tissue half-life (T1/2) of ca. 1 min (Fig. 4a, Table 1). There was 
no statistical difference in the kinetics of theophylline clearance from the lungs when 
theophylline was administered alone or as a spermine ion-pair (p > 0.05) (Table 1). However, 
following the 10 min washout period, the mass of theophylline remaining in the lungs was 
significantly higher when the theophylline-spermine ion-pair was administered compared to 
when the non-ion-paired control was infused, i.e., a 1.7 ± 1.1-fold increase using the water 
vehicle and a 2.8 ± 1.3-fold increase using the propylene glycol vehicle compared to the control 
(Fig. 4b). 
 
Theophylline lung uptake was not significantly altered in the presence of blood proteins 
compared to Krebs (SS(Krebs) = 25.4 ± 7.2 µg and SS(blood)= 25.2 ± 1.6 µg (p > 0.05)) when 
theophylline was administered alone. Theophylline is known to be extensively plasma protein 
bound, hence the presence of the plasma proteins would be expected to deplete the theophylline 
available for lung uptake and thus reduce the theophylline transport if it was primarily taken 
up via passive transport. The fact that the plasma proteins did not influence the theophylline 
transport into the lungs suggested that the drug did not simply enter the lung tissue via a passive 
process. However, the presence of the plasma proteins did increase the clearance and reduce 
the half-life of the theophylline in the re-circulatory system (supplementary data table S1). 
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Figure 4.  a) Theophylline (THE) and theophylline-spermine ion-pair in water (THE-SPE) (n 
= 3-4 ± SD) clearance from the lung (note clearance data not collected for the ion-pair in water 
and propylene glycol (THE-SPE(PG)). Inset displays the second-order kinetic fit of the data 
during the first 5 min of the post-perfusion period. (b) THE retained in the isolated perfused 
lung tissue after the 10 minute washout period (n = 3 ± SEM) *denotes difference compared to 
THE control (ANOVA, p < 0.05). 
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Figure 5. a) Theophylline (THE) lung uptake from a continuous ‘recycled’ perfusate of 
blood:steen mixture into which THE (●) and THE-SPE ion-pair (○) dissolved in water were 
spiked (n = 4-5 ± SEM). b) Theophylline clearance from the lung tissue during the washout 
period following perfusion of THE (●) and THE-SPE (○) (n =3-4 ± SD). 
 
 
Lung uptake of the theophylline-spermine ion-pair was enhanced in the re-circulating 
IPL compared to free theophylline, but the magnitude of the enhancement was lower when 
compared to the single pass IPL system; 2-fold at the start of the experiment (t = 1-6 min) 
falling to 1.2-fold after 25 min (Fig. 5a). Statistical analysis indicated that only 3 time points 
(at 8, 10 and 25 min) did not show a statistical difference between the theophylline and the 
theophylline-spermine ion-paired formulation. The reduction in ion-pair lung uptake 
enhancement compared to the single pass system was presumably due to dissociation of the 
ion-pair over time in the re-circulating perfusate.  It is also possible that spermine was oxidised 
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by serum oxidases as we avoided using amino-oxidase inhibitors, such as aminoguanidine, 
because of their potential to ion-pair with theophylline and confound observations. 
 
3.4 Ion-pair dissociation 
 
Dissociation studies were carried out to mimic the infusion of the formulation (pH 9.6) 
into the IPL perfusate (pH 7.4). The pH of the formulation (pH 9.6 at t = 0) was reduced by the 
addition of HCl, mixed to achieve a final pH of 7.4, then analysed using an FTIR 
spectrophotometer. The process took 46 s, which was longer than the 5 s required for the ion-
pair formulation to travel from the site of infusion to the lung tissue in the IPL studies. 
Unfortunately, 46 s represented the shortest time in which complete mixing could be assured 
in the static FTIR cell. The FTIR results showed that the theophylline peaks assigned to the 
ion-pair species (in D2O: C2=O – 1673; C6=O – 1619; C-N7 – 1535 cm-1) had reverted to the 
peaks assigned to the non-ion-paired species (in D2O: C2=O – 1696; C6=O – 1645; C-N7 – 
1551 cm-1, Figure 6). These data suggested that the pH change induced ion-pair breakdown. 
However, the shoulder at 1619 cm-1 in D2O spectra confirmed that a small proportion of ion-
paired theophylline existed even when the pH was dropped to 7.4. This result was in accordance 
with the calculations using the pKa of the drug, that ca. 7% of the theophylline was likely to 
remain ionised at pH 7.4 (Marvin Sketch, ChemAxon Ltd) of which the Hyss calculations 
predicted 0.4% of the total theophylline dose would remain ion-paired (Figure S1). In the 
D2O/PG vehicle the peak at 1619 cm
-1 could not be seen clearly as all the peaks moved to lower 
wavenumbers, thus the proportion of ion-pairs that remained in water could not be compared 
with PG. After 20 min there were several small peaks around the 1530 cm-1 region of the FTIR 
spectrum, which suggested that after ion-pair dissociation a small proportion of theophylline 
dimers were formed. The formation of theophylline dimers has been previously reported to 
occur in water at the concentrations used in the FTIR work 24. 
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Figure 6. Theophylline–spermine ion-pair dissociation kinetics in a) D2O and b) 70/30 
PG/D2O. The ion-pairs were formed in the vehicles at pH 9.6, t=0 and the pH was then dropped 
to physiological pH 7.4 over 46 s using HCl. 
 
Discussion 
 
The FTIR data generated in this study showed that theophylline and spermine formed 
ion-pairs in polar solutions at pH 9.6. In this alkaline environment, the N1 amine was the most 
extensively ionised of spermine’s 4 amine groups (97% ionised) and therefore it was proposed 
to preferentially associate with the charged C-N7 of theophylline. This hydrogen bond would 
orientate the spermine N2 and the theophylline C6=O such that a second hydrogen bond was 
possible. The C-N7 and C6=O peak shifts in the theophylline FTIR trace, assigned to 
conformational restriction caused by ion-pair formation and the C2=O peak shifts, assigned to 
electron distribution changes in the ring of theophylline supported the suggestion that 2 
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hydrogen bonds were formed20. The affinity constant of the theophylline spermine ion-pair also 
suggested that the complex had two points of interaction because it was held together more 
strongly than a simple ion-pair that was formed from a single electrostatic interaction such as 
KCl (KAss is -0.7) 
19. The theophylline-spermine ion-pair supressed the charge on the 
theophylline compared to the theophylline alone22. However, in silico modelling of the ion-
pair association using the affinity constant demonstrated that the complex was prone to break 
down rapidly upon a drop in pH or large dilution (i.e., the conditions experienced upon 
administration to the IPL). The addition of the propylene glycol co-solvent to the water vehicle 
enhanced the theophylline spermine interactions. These enhanced ion-pair interactions were 
most likely caused by the weakening the water’s supramolecular structure in the solvent, which 
has previously been shown to promote hydrogen-bond interactions 25. When evaluated in cell 
culture and IPL systems it was apparent that the physical stability of ion-pairs was fundamental 
to their uptake by the lungs and thus control of this aspect will be essential in order to 
successfully exploit this drug targeting approach. 
 
The Km and Vmax of the spermidine uptake in the A549 cells in this study was similar 
to previously reported work where the PTS was shown to be active and this provided evidence 
that PTS transporter was functional in the A549 cells 2. Theophylline uptake into the cells was 
low, approximately 0.05 ng in 2 minutes, after which theophylline concentration did not 
increase in the cells suggesting that equilibrium conditions were achieved rapidly. The 
enhancement of transport during the rapid theophylline uptake phase was energy dependent 
and attributed to PTS which transports spermine and was functional in the A549 cells 
(Supplementary information S2). The initial enhancement of uptake in the cell culture system 
with lack of further effect after the first measurement at 2 minutes was consistent with the 
timeframe for PTS uptake of the complex initially with the effect terminated after the actively 
transported ion pair dissociated. Definitive confirmation of PTS facilitated uptake was hindered 
by lack of a specific PTS inhibitor. However, alternative explanations such as active transport 
by other transporters and/or enhanced passive uptake of the ion-pair or were considered 
unlikely. Formation of the ion-pair adds two charged amines to the drug complex, which is not 
favourable for passive membrane transport26. In addition, recent studies have shown that the 
OCT mechanism is 30-fold less efficient at moving amines into cells compared to the PTS27.  
In the cell culture studies, the spermine concentration (SPE at 3.3 mM) used exceeded the PTS 
Km (at 0.02 mM), hence, the free spermine, which is required to force ion-pair formation, was 
competing for the saturated PTS with the ion-paired THE-SPE. However, theophylline 
22 
 
transport was more than 100 times slower than spermine transport and therefore an ion-pair 
binding ratio of 1 out of every 20 spermine molecules being ion-paired was sufficient to 
enhance cell uptake2.   
  
The data from the IPL experiments supported the suggestion generated by the cell 
culture work, viz., that ion-pairing with spermine enabled active transport of theophylline into 
the lung tissue. Control experiments showed that the increased theophylline uptake was not a 
consequence of using a formulation with pH of 9.6, nor did the presence of unpaired spermine 
alter the lung uptake of theophylline. The effects of the ion-pair were more pronounced and 
sustained in the IPL compared to the cell culture model. This may have been a consequence of 
differences in (i) the method of delivery, i.e. constant replenishment by infusion of ion-paired 
drug in the IPL, (ii) levels of transporter activity in the cell vs intact organ models, (iii) access 
to the different cell types and tissue structures in the IPL28,29. The current work suggests for the 
first time that PTS will not only extract polyamines from the circulation into the lung, but can 
also transport therapeutic agents which can ion-pair to a polyamine. The effectiveness of the 
ion-pair formulation approach for enhancing theophylline uptake via PTS-mediated drug 
transport opens up more generalised possibilities to modify drug disposition in the lungs using 
similar technology. For example, ion-pairing could be used to reduce affinity for a promiscuous 
transporter such as p-glycoprotein, which would be applicable to a much wider range of drugs 
and could utilise a much wider range of counter ion candidates. 
 
Theophylline has a narrow therapeutic index in the clinic, particularly when 
administered systemically for the acute treatment of asthma and chronic obstructive pulmonary 
disease (COPD). Our lung uptake data showed that the theophylline had a low affinity to the 
lung tissue (its tissue half-life was ca. 1 min). This supported previous data 30, and suggested 
that the low extraction of the drug into the lung tissue was a contributing factor to its 
unfavourable pharmacokinetic profile 31, 32. However, when theophylline was delivered as an 
ion-pair significantly more of the drug remained in the lungs after a 10 min wash out period 
compared with administration as free drug and this supported the notion that the ion-pair 
facilitated lung targeting. It is unknown whether this effect was a result of ion-pair persistence 
in the lungs or targeting to compartments in the lung tissue where the dissociated theophylline 
formed a reservoir.  Even in the re-circulating IPL system in which the ion-pair complex almost 
completely dissociates after bolus administration, there was increased lung uptake after 25 min 
recirculation. The dynamics of ion-pair break down have previously been shown to be retarded 
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in the presence of buffers using the model agents anthracene and tetranitromethane 33. 
However, in the absence of excess counter-ions the breakdown for these compounds still 
occurred rapidly, over µs, rather than the time course of the IPL experiments 33. This 
discontinuity between the measurement of pharmaceutical ion-pair stability in model systems 
and those in biological systems is at present irresolvable because of the complexity of making 
accurate analytical measurements in the presence of proteins and salts. 
 
Conclusion 
 
Results from the cell culture and IPL experiments indicated that therapeutic ion-pairs 
formed with a PTS substrate as the counter ion can target drug to the lungs via the PTS system.  
Modifying the ion-pair delivery vehicle to increase the physical stability of the ion-pairs 
enhanced the uptake into the lung suggesting that formulation selection can modulate the 
polyamine-based uptake process. Using a non-covalent complex to target the PTS appears to 
have merit over covalently linked systems because the active agent is presented in its original 
form upon dissociation, which mitigates a number of pharmacological, toxicology and 
regulatory issues associated with the clinical use of covalently conjugated drug targeting 
systems. In the case of theophylline, selective delivery to the lungs would improve its 
therapeutic window and increase the safety of the drug when used in the treatment of asthma 
and COPD. However, the pH dependence and dynamics of theophylline ion-pairing means that 
it could not be used orally and thus it would be limited to intravenous use of theophylline for 
the treatment of acute asthma and COPD where a rapid selective delivery to lung tissue is 
required. It is promising however that the same approach can be applied to other therapeutic 
classes of compounds. For example, there are several anionic anticancer agents, which if ion-
paired with polyamines could take advantage of the overexpression of the PTS system in 
rapidly dividing cells as a means of selective drug delivery. 
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